Pulmocide Announces Successful Results from the OPERA-S Study: a Phase 2 Safety Study with Inhaled Opelconazole April 23, 2024
AAVantgarde Presents Positive Preclinical Data in Large Animal Models from its Stargardt Disease Program in an Oral Presentation at the ASGCT 2024 Annual Meeting April 23, 2024
TScan Therapeutics Provides Clinical Pipeline Update and Highlights Near-Term Priorities April 17, 2024
Immunitas Therapeutics Presents Preclinical Data Supporting Combination of IMT-009 with Anti-PD1 Immunotherapy at the AACR April 9, 2024
Werewolf Therapeutics Presents Preclinical Results Demonstrating Anti-Tumor Effects of Pro-Inflammatory Cytokine Therapeutics WTX-518 and WTX-712 at AACR April 7, 2024
